2024-16096. Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising
-
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA or Agency) is announcing that a collection of information entitled “Electronic Records: Electronic Signatures” has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (PRA).
FOR FURTHER INFORMATION CONTACT:
Amber Sanford, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-8867, PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
On December 21, 2023, the Agency submitted a proposed collection of information entitled “Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising” to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910-0929. The approval expires on June 30, 2027. A copy of the supporting statement for this information collection is available on the internet at https://www.reginfo.gov/public/do/PRAMain.
Dated: July 17, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024-16096 Filed 7-22-24; 8:45 am]
BILLING CODE 4164-01-P
Document Information
- Published:
- 07/23/2024
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice.
- Document Number:
- 2024-16096
- Pages:
- 59742-59742 (1 pages)
- Docket Numbers:
- Docket No. FDA-2023-N-0795
- PDF File:
- 2024-16096.pdf
- Supporting Documents:
- » Reference 7 - Shengchao-s12874-017-0353-1 RE Agency Information Collection Activities; Proposed Collection; Comment Request; A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising
- » Reference 3 - Cheung - s12874-019-0786-9 RE Agency Information Collection Activities; Proposed Collection; Comment Request; A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising
- » Reference 1 - Sullivan - nihms-819225 RE Agency Information Collection Activities; Proposed Collection; Comment Request; A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising